ARKG is trading at $41.66 (-3.10%) amid sector-wide pressure from healthcare policy concerns and a broader risk-off market tone.
- The healthcare sector is facing headwinds from ongoing debates over payment cuts, drug pricing legislation, and insurer utilization management.
- Fragile market sentiment, driven by geopolitical stress and higher oil prices, is further weighing on high-growth risk assets.
- ARKG’s heavy exposure to healthcare innovation is likely amplifying the impact of these combined sector and macroeconomic pressures.